ATLASEnveric Biosciences (ENVB) earnings date: Nov 13, 2026
Enveric Biosciences (ENVB) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ENVB
| Last price | $1.43 (-2.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.6% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Enveric Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Enveric Biosciences reports on Nov 13, 2026. One email the day before, with ATLAS’s read on Enveric Biosciences. You can switch it off at any time.
Alert me before ENVB reportsFree to start. Creating an account takes under a minute.
ENVB earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Apr 30, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +32.5% |
| Average move around a report | ±9.7% (last 5) |
| Sector | Healthcare · Biotechnology |
Enveric Biosciences earnings history: last 5 reports
Enveric Biosciences last reported on Apr 30, 2026: EPS of $2.68 against an estimate of $2.03 (+32.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Apr 30, 2026 | $2.03 | $2.68 | +32.0% | Beat | -22.7% |
| Feb 23, 2026 | $1.01 | $0.59 | -41.6% | Miss | -0.9% |
| Sep 23, 2025 | $1.23 | $2.36 | +91.9% | Beat | +1.0% |
| Mar 28, 2025 | -$2.76 | -$2.03 | +26.5% | Beat | -13.1% |
| Nov 14, 2024 | -$93.60 | -$43.20 | +53.8% | Beat | -10.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ENVB
See the fair value, the probability range and the earnings history of Enveric Biosciences on its ATLAS page.
Enveric Biosciences (ENVB) stock analysisPlans from €3.99 a month.
Enveric Biosciences earnings: frequently asked questions
When does Enveric Biosciences (ENVB) report earnings?
Enveric Biosciences is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does ENVB beat earnings estimates?
Of its last 5 reports with a recorded result, Enveric Biosciences beat the EPS estimate 4 times; the average surprise was +32.5%. Past results do not predict the next one.
How much does ENVB move around earnings?
Over its last 5 reports the stock moved an average of 9.7% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Enveric Biosciences beat earnings estimates last quarter?
Enveric Biosciences last reported on Apr 30, 2026: EPS of $2.68 against an estimate of $2.03 (+32.0% surprise), a beat.
How much does ENVB usually move in a day?
On a normal trading day the ATLAS model puts ENVB’s one-day range at about ±3.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer